TFS
GWPH

TrustCore Financial Services’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

TrustCore Financial Services’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-183
Closed -$40K – 1134
2021
Q1 		$40K Sell
183
-100
-35% -$18.8K ﹤0.01% 480
2020
Q4 		$33K Hold
283
– – ﹤0.01% 478
2020
Q3 		$28K Sell
283
-25
-8% -$2.88K ﹤0.01% 462
2020
Q2 		$38K Buy
308
+25
+9% +$2.84K 0.01% 432
2020
Q1 		$25K Hold
283
– – 0.01% 453
2019
Q4 		$30K Buy
283
+100
+55% +$11.2K 0.01% 460
2019
Q3 		$21K Buy
183
+83
+83% +$12.6K ﹤0.01% 509
2019
Q2 		$17K Hold
100
– – ﹤0.01% 545
2019
Q1 		$17K Buy
+100
New +$14.9K ﹤0.01% 469

Other funds holding GWPH

HDIM
Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

TrustCore Financial Services's GWPH Position: Q2 2021 in Review

TrustCore Financial Services sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 183 shares — an estimated $40K sold.

TrustCore Financial Services first reported a position in GWPH in Q1 2019 and held it in 9 quarters. The position peaked at $40K in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

  • TrustCore Financial Services reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
  • TrustCore Financial Services sold 183 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $40K.
  • TrustCore Financial Services first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2019 and held it in 9 quarters.
  • TrustCore Financial Services's GW Pharmaceuticals Plc American Depositary Shares position peaked at $40K in Q1 2021.
  • 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on TrustCore Financial Services's 13F filing for Q2 2021, filed 2 Aug 2021.